Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Springworks Therapeutics, Inc. (SWTX)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 79,266,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   SpringWorks Therapeutics a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing medicines for underserved patient populations suffering from devastating rare diseases and cancer. Co.'s product candidate, nirogacestat, is an oral, small molecule gamma secretase inhibitor in development as a monotherapy for the treatment of desmoid tumors, a rare and often debilitating and disfiguring soft tissue tumor. Co.'s second product candidate is mirdametinib, an oral, small molecule MEK inhibitor initially in development for the treatment of neurofibromatosis type 1-associated plexiform neurofibromas.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 49,237 49,237 54,055 2,234,484
Total Sell Value $2,293,323 $2,293,323 $2,428,802 $67,748,752
Total People Sold 2 2 3 5
Total Sell Transactions 4 4 6 12
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 184
  Page 1 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Ashar Bhavesh Chief Commercial Officer   •       –      –    2024-04-01 4 D $47.62 $86,859 D/D (1,824) 56,330     -
   Pichl Daniel Chief People Officer   •       –      –    2024-02-16 4 AS $50.10 $751,550 D/D (15,000) 45,212     -
   Pichl Daniel Chief People Officer   •       –      –    2024-02-16 4 OE $27.64 $414,600 D/D 15,000 60,212     -
   Ashar Bhavesh Chief Commercial Officer   •       –      –    2024-02-05 4 AS $49.32 $238,435 D/D (4,834) 58,154     -
   Pichl Daniel Chief People Officer   •       –      –    2024-02-02 4 AS $43.81 $1,160,362 D/D (26,181) 45,212     -
   Pichl Daniel Chief People Officer   •       –      –    2024-02-02 4 OE $27.64 $449,150 D/D 16,250 71,393     -
   Ashar Bhavesh Chief Commercial Officer   •       –      –    2024-02-02 4 AS $43.75 $142,976 D/D (3,222) 62,988     -
   Ashar Bhavesh Chief Commercial Officer   •       –      –    2024-01-08 4 D $41.53 $60,177 D/D (1,449) 66,210     -
   Edris Badreddin Chief Operating Officer   •       –      –    2024-01-08 4 D $41.53 $227,003 D/D (5,466) 269,600     -
   Islam Saqib Chief Executive Officer   •       •      –    2024-01-08 4 D $41.53 $743,553 D/D (17,904) 256,264     -
   Nofi Michael Chief Accounting Officer   •       –      –    2024-01-08 4 D $41.53 $44,146 D/D (1,063) 28,727     -
   Cassidy James Chief Medical Officer   •       –      –    2024-01-08 4 D $41.53 $45,392 D/D (1,093) 76,416     -
   Smith L. Mary Chief Development Officer   •       –      –    2024-01-08 4 D $41.53 $146,809 D/D (3,535) 233,363     -
   Francis Perier I Jr Chief Financial Officer   •       –      –    2024-01-08 4 D $41.53 $133,519 D/D (3,215) 59,253     -
   Pichl Daniel Chief People Officer   •       –      –    2024-01-08 4 D $41.53 $58,350 D/D (1,405) 55,143     -
   Weinstein Herschel S General Counsel & Secretary   •       –      –    2024-01-08 4 D $41.53 $100,627 D/D (2,423) 52,239     -
   Ashar Bhavesh Chief Commercial Officer   •       –      –    2024-01-05 4 D $37.96 $95,166 D/D (2,507) 67,659     -
   Edris Badreddin Chief Operating Officer   •       –      –    2024-01-05 4 D $37.96 $169,643 D/D (4,469) 275,066     -
   Islam Saqib Chief Executive Officer   •       •      –    2024-01-05 4 D $37.96 $489,115 D/D (12,885) 274,168     -
   Nofi Michael Chief Accounting Officer   •       –      –    2024-01-05 4 D $37.96 $44,375 D/D (1,169) 29,790     -
   Cassidy James Chief Medical Officer   •       –      –    2024-01-05 4 D $37.96 $89,472 D/D (2,357) 77,509     -
   Smith L. Mary Chief Development Officer   •       –      –    2024-01-05 4 D $37.96 $83,398 D/D (2,197) 236,898     -
   Francis Perier I Jr Chief Financial Officer   •       –      –    2024-01-05 4 D $37.96 $81,652 D/D (2,151) 62,468     -
   Pichl Daniel Chief People Officer   •       –      –    2024-01-05 4 D $37.96 $59,749 D/D (1,574) 56,548     -
   Weinstein Herschel S General Counsel & Secretary   •       –      –    2024-01-05 4 D $37.96 $88,219 D/D (2,324) 54,662     -
  184 Records found
  1  2  3  4  5  6  7  8   
  Page 1 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us